Genotropin 36 IU Pfizer Labs

 

Information for those wishing to buy Genotropin 36 IU in the UK

In the human body, growth hormone is produced by the pituitary gland. Its levels are especially high during adolescence, when it promotes tissue growth, protein deposition and breakdown of subcutaneous fat reserves. After adolescence, endogenous levels of GH decrease, but remain at much lower levels in the body. In the body, the actual structure of growth hormone is a sequence of 191 amino acids. Once scientists isolated this hormone, many people were convinced that it had exceptional therapeutic properties. It would be particularly effective in pituitary dwarfism, the drug would probably restore linear growth if taken during adolescence.

How to use Genotropin 36 IU from Pfizer Labs

The use of Genotropin 36 IU growth hormone is becoming increasingly popular among UK athletes, which of course is due to the many benefits associated with its use. To start with, GH stimulates the growth of most body tissues, mainly by increasing the number of cells, not their size. This applies to skeletal muscle tissue and, with the exception of the eyes and brain, to all other organs of the body. The transport of amino acids and the rate of protein synthesis are also increased.

All these effects are mediated by IGF-1 (insulin-like growth factor), an anabolic hormone, which is produced in the liver and other tissues in response to the growth hormone (IGF-1 levels peak around 20 hours after taking HGH). Genotropin 36 IU growth hormone itself also stimulates the hydrolysis of triglycerides in adipose tissue, which usually results in a marked loss of fat during treatment. GH also increases glucose production in the liver and causes insulin resistance by blocking the activity of this hormone in target cells. There is a shift where fat becomes a more primary source of fuel, further enhancing fat loss.

Packaging video review Genotropin 36 IU Pfizer Labs

 

 

 

 

Effects of Genotropin 36 IU by Pfizer Labs:

• Increase in lean muscle mass;
• Protect muscle from degradation;
• Burn fat deposits;
• Accelerated regeneration;
• Rejuvenation effect;
• Bone growth in athletes up to 26 years of age;
• Strengthening of bones and ligaments;
• Strengthening of the immune system.

Dosage of Genotropin 36 IU by Pfizer Labs

For best results, the average male athlete usually requires a dosage in the range of 4 to 6 IU per day. At a low level, 1 to 2 IU per day can be used, but it is still a significant expense. The daily dosage of Genotropin from Pfizer Labs is very important as HGH has a very short life span in the body. The peak concentration in the blood is noted quickly (2-6 hours) after injection, and the hormone is eliminated from the body with a half-life of only 20-30 minutes. Obviously, it does not stay in the body for long, which makes it difficult to maintain stable levels in the blood.

The effects of Genotropin 36 IU are also most pronounced with long term use, often over many months. Some people use it for shorter periods as well, but usually only for fat loss purposes. A cycle of at least four weeks is used for this purpose. This compound can be injected both intramuscularly and subcutaneously. “Subcutaneous injections in particular cause localised fat loss, which requires the user to change injection points regularly to even out the effect. Overall fat loss seems to be the only characteristic most people agree on. The fat-burning properties of this drug seem to be faster and less dependent on high doses.

For best results, other drugs should be used together with HGH. Your body requires an increased amount of thyroid hormones, insulin and androgens when HGH levels are elevated (in fact, Genotropin 36 IU therapy lowers thyroid hormone and insulin levels). To start with, adding thyroid hormones greatly increases the thermogenic efficiency of the cycle. Take Cytomel or Synthroid. (prescription versions of T-3 and T-4) seems to make the most sense (the more potent Cytomel? usually preferred). Insulin is also very useful during the cycle, most often used in an anabolic routine.

In addition to replenishing lowered insulin levels, the use of this hormone is important because it can sensitise IGF-1 receptors and lower the IGF-binding protein-1, which allows more IGF-1 to circulate freely (growth hormone itself also lowers IGF-binding protein levels). Steroids also prove to be very necessary for Genotropin 36 IU to show its full anabolic effect. In particular, something with a noticeable androgenic component should be used, such as testosterone or trenbolone (if estrogen is a concern).

An additional androgen is quite useful because it promotes anabolism by increasing muscle cell size (remember that GH primarily affects cell count). Steroid use can also increase free IGF-1 via reduction of IGF-binding proteins. The combination of all these drugs (HGH, anabolics, insulin and T-3) appears to be most synergistic, providing clearly enhanced results. Of course, it is important to note that thyroid drugs and insulin are particularly potent drugs, which have a number of additional risks.

GH and IGF-1 release and action: GHRH (growth hormone releasing hormone) and SST (somatostatin) are released by the hypothalamus to stimulate or inhibit pituitary GH production. Genotropin 36 IU has a direct effect on many tissues, as well as an indirect effect through the production of IGF-1. IGF-1 also causes inhibition of negative feedback in the pituitary and hypothalamus. Increased somatostatin release affects not only GH release, but also insulin and thyroid hormones.

Side effects

Genotropin 36 IU itself carries certain risks. The most commonly discussed side effect is acromegaly, or marked thickening of the bones (particularly the feet, forehead, hands, jaw and elbows). The drug can also enlarge vital organs such as the heart and kidneys, and has been linked to hypoglycaemia and diabetes (presumably because of its ability to induce insulin resistance). Theoretically, excessive use of this hormone can lead to a number of diseases, some of which are life-threatening. However, such problems are extremely rare.

Among many English athletes using growth hormone, we have very few documented cases of serious problems developing. When used intermittently in a moderate dosage, the athlete should have no cause for concern. Of course, if any noticeable changes in bone structure, skin structure or normal wellbeing occur during the use of growth hormone, HGH therapy should be stopped completely.